<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">JCN</journal-id>
<journal-id journal-id-type="hwp">spjcn</journal-id>
<journal-id journal-id-type="nlm-ta">J Child Neurol</journal-id>
<journal-title>Journal of Child Neurology</journal-title>
<issn pub-type="ppub">0883-0738</issn>
<issn pub-type="epub">1708-8283</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage CA: Los Angeles, CA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/0883073812441061</article-id>
<article-id pub-id-type="publisher-id">10.1177_0883073812441061</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Brief Communication</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Intramedullary Spinal Cord Primitive Neuroectodermal Tumor Presenting With Hydrocephalus</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Alexiou</surname>
<given-names>George A.</given-names>
</name>
<degrees>MD, PhD</degrees>
<xref ref-type="aff" rid="aff1-0883073812441061">1</xref>
<xref ref-type="corresp" rid="corresp1-0883073812441061"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Siozos</surname>
<given-names>George</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff2-0883073812441061">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Stefanaki</surname>
<given-names>Kalliopi</given-names>
</name>
<degrees>MD, PhD</degrees>
<xref ref-type="aff" rid="aff2-0883073812441061">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Moschovi</surname>
<given-names>Maria</given-names>
</name>
<degrees>MD, PhD</degrees>
<xref ref-type="aff" rid="aff3-0883073812441061">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Prodromou</surname>
<given-names>Neofytos</given-names>
</name>
<degrees>MD, PhD</degrees>
<xref ref-type="aff" rid="aff1-0883073812441061">1</xref>
</contrib>
</contrib-group>
<aff id="aff1-0883073812441061">
<label>1</label>Department of Neurosurgery, Children’s Hospital “Agia Sofia,” Athens, Greece</aff>
<aff id="aff2-0883073812441061">
<label>2</label>Department of Pathology, Children’s Hospital “Agia Sofia,” Athens, Greece</aff>
<aff id="aff3-0883073812441061">
<label>3</label>Hematology Oncology Unit of 1st Department of Pediatrics of Athens University, Children’s Hospital “Agia Sofia,” Athens, Greece</aff>
<author-notes>
<corresp id="corresp1-0883073812441061">George A. Alexiou, MD, Department of Neurosurgery, Children’s Hospital “Agia Sofia,” Aetideon 52, Holargos, Attikis, 11561, Greece. Email: <email>alexiougrg@yahoo.gr</email>
</corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>2</month>
<year>2013</year>
</pub-date>
<volume>28</volume>
<issue>2</issue>
<fpage>246</fpage>
<lpage>250</lpage>
<history>
<date date-type="received">
<day>28</day>
<month>11</month>
<year>2011</year>
</date>
<date date-type="accepted">
<day>11</day>
<month>2</month>
<year>2012</year>
</date>
</history>
<permissions>
<copyright-statement>© The Author(s) 2013</copyright-statement>
<copyright-year>2013</copyright-year>
<copyright-holder content-type="sage">SAGE Publications</copyright-holder>
</permissions>
<abstract>
<p>Spinal primitive neuroectodermal tumors are exceedingly rare. Herewith, we present the first case of an intramedullary spinal cord tumor associated with hydrocephalus in a 2-month-old boy that presented with left hemiparesis. The patient had been diagnosed on prenatal ultrasound with enlarged ventricular system. At his current admission, a brain magnetic resonance imaging (MRI) revealed hydrocephalus and an intramedullary lesion extending from the second cervical to the first thoracic vertebrae. Dissemination of the tumor was revealed intracranially and in the spinal canal. After a ventriculoperitoneal shunt placement a radical resection of the tumor was performed, however some small tumor remnants could not be safely removed. Postoperative there was no neurologic deterioration. The tumor was diagnosed as a central nervous system primitive neuroectodermal tumor (World Health Organization grade IV). Spinal intramedullary primitive neuroectodermal tumors are extremely rare. In such rare tumors, multiinstitutional studies are needed for treatment guidelines to be established.</p>
</abstract>
<kwd-group>
<kwd>primitive neuroectodermal tumor</kwd>
<kwd>spine</kwd>
<kwd>intramedullary tumor</kwd>
<kwd>hydrocephalus</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<p>Intramedullary spinal cord tumors in childhood are relatively rare. Spinal primitive neuroectodermal tumors are exceedingly rare, and only few cases in children have been reported to date.<sup><xref ref-type="bibr" rid="bibr1-0883073812441061">1</xref><xref ref-type="bibr" rid="bibr2-0883073812441061"/>–<xref ref-type="bibr" rid="bibr3-0883073812441061">3</xref></sup> Furthermore, hydrocephalus in patients with spinal cord tumors has rarely been reported.<sup><xref ref-type="bibr" rid="bibr4-0883073812441061">4</xref>,<xref ref-type="bibr" rid="bibr5-0883073812441061">5</xref></sup> In this view, we present the first case of an intramedullary spinal cord primitive neuroectodermal tumor associated with hydrocephalus in an infant.</p>
<sec id="section1-0883073812441061">
<title>Case Report</title>
<p>A 2-month-old boy presented with a left hemiparesis. Skin stigmata such as hair, dimple, or mass were not found. The patient had been diagnosed on prenatal ultrasound with an enlarged ventricular system. At 33 weeks' gestation, a fetal magnetic resonance imaging (MRI) was performed in another institute that revealed asymmetry of the lateral ventricles with mild dilation of the left lateral ventricle (<xref ref-type="fig" rid="fig1-0883073812441061">Figure 1</xref>). The infant was delivered by Caesarean section at full term, with a birth weight of 3020 g. No further investigation was performed until his current admission. In our institute, a brain and spinal MRI was performed that revealed hydrocephalus and a 4.7 × 1.5 cm intramedullary lesion extending from the second cervical to the first thoracic vertebrae. The lesion was isointense on T1-weighted images, hyperintense on T2-weighted images, and enhanced after contrast administration (<xref ref-type="fig" rid="fig2-0883073812441061">Figure 2</xref>). Dissemination of the tumor was revealed intracranially and in the spinal canal (<xref ref-type="fig" rid="fig2-0883073812441061">Figures 2C</xref> and <xref ref-type="fig" rid="fig3-0883073812441061">3</xref>). Astrocytoma, ependymoma, and atypical teratoid/rhabdoid tumor were considered in the differential diagnosis. The patient was operated on. First, a ventriculoperitoneal shunt was placed and then the tumor was excised. A radical resection was performed; however, some small tumor remnants could not be safely removed. Post operation, there was no neurologic deterioration.</p>
<fig id="fig1-0883073812441061" position="float">
<label>Figure 1.</label>
<caption>
<p>Coronal image of fetal magnetic resonance imaging using the half-Fourier-acquisition single-shot turbo spin-echo sequence at 33 weeks' gestation revealing mild dilation of the left lateral ventricle.</p>
</caption>
<graphic alternate-form-of="fig1-0883073812441061" xlink:href="10.1177_0883073812441061-fig1.tif"/>
</fig>
<fig id="fig2-0883073812441061" position="float">
<label>Figure 2.</label>
<caption>
<p>(A) Sagittal T1-weighted magnetic resonance imaging showing a lesion extending from the second cervical to the first thoracic vertebra. (B) Marked enhancement after gadolinium administration. (C) Dissemination of the tumor.</p>
</caption>
<graphic alternate-form-of="fig2-0883073812441061" xlink:href="10.1177_0883073812441061-fig2.tif"/>
</fig>
<fig id="fig3-0883073812441061" position="float">
<label>Figure 3.</label>
<caption>
<p>Axial T1-weighted magnetic resonance imaging after gadolinium infusion revealing intracranial tumor dissemination as nodular enhancing lesions.</p>
</caption>
<graphic alternate-form-of="fig3-0883073812441061" xlink:href="10.1177_0883073812441061-fig3.tif"/>
</fig>
<p>The histologic examination showed fragments of a malignant central nervous system embryonal tumor with moderately to highly increased cellularity and morphologic heterogeneity. The neoplasm mainly comprised (a) moderately cellular areas composed of neuropil and clusters of small- to medium-sized cells with limited eosinophilic cytoplasm and a nucleus with fine chromatin, and (b) alternating highly cellular areas composed of small cells with a scarce cytoplasmic rim and mild to moderate nuclear atypia. A heterogenous moderate to brisk mitotic activity (12-50 mitoses/10 high-power field, ×40) was observed, while apoptotic bodies and rare giant neoplastic cells were seen. Characteristic features were (a) the neuroblastic Homer Wright rosettes and perivascular arrangement of neuropil and (b) the streaming of the neoplastic cells in the hypocellular areas, the presence of neurocytoma-like and ganglion cells. Foci of geographic/palisading necrosis (10% of the tumor), rare glomeruloid vascular hyperplasia, and single psammoma body were seen (<xref ref-type="fig" rid="fig4-0883073812441061">Figure 4</xref>). Immunohistochemistry revealed expression of synaptophysin in the neoplastic cells, which was higher in areas with reduced cellularity, diffuse expression of B Tubulin III, heterogenous expression of neurofilament protein (&gt;25%) and nuclear expression of neuronal nuclei (20%-30%) mainly in areas with neuronal differentiation. There was no expression of cytokeratin 8.18, glial fibrillary acidic protein, epithelial membrane antigen, and CD99, whereas the nuclear expression of INI-1/BAF47 protein was retained in all tumor cells. Ki-67/MIB-1 proliferative index was detected in more than 30% of tumor cells (<xref ref-type="fig" rid="fig5-0883073812441061">Figure 5</xref>). P-53 protein was expressed in 20% of the tumor nuclei, and bcl-2 protein was revealed in the cytoplasm of &gt;90% of the neoplastic cells. Based on the morphologic and immunophenotypic features, the tumor was diagnosed as a central nervous system primitive neuroectodermal tumor (World Health Organization grade IV). The patient was referred to the hematology oncology department and treated with the Head Start II protocol.<sup><xref ref-type="bibr" rid="bibr6-0883073812441061">6</xref></sup> On follow-up examination 9 months later, no tumor recurrence was noted.</p>
<fig id="fig4-0883073812441061" position="float">
<label>Figure 4.</label>
<caption>
<p>(A) Cellular area of primitive neuroectodermal tumor with Homer Wright rosettes and geographic necrosis. (B) Streaming and obvious mitoses (×400). (C) Area with moderate/reduced cellularity and obvious neuronal differentiation. (D) Hypocellular area with neuronal differentiation, streaming, and perivascular arrangement of neoplastic cells. (E) Homer Wright rosettes and giant cells, severe nuclear atypia. (F) Area of increased cellularity and perivascular rosettes.</p>
</caption>
<graphic alternate-form-of="fig4-0883073812441061" xlink:href="10.1177_0883073812441061-fig4.tif"/>
</fig>
<fig id="fig5-0883073812441061" position="float">
<label>Figure 5.</label>
<caption>
<p>(A) Synaptophysin expression mainly in the neuropil and neoplastic cells. (B) Glial fibrillary acidic protein expression only in the residual perivascular astrocytes. (C) β-Tubulin III expression. (D) Neuronal nuclei expression in 10% of the nuclei. A ganglion cell is positive in the upper right corner. (E) INI-1 protein was retained in the nuclei of all neoplastic cells &gt;95%. (F) Ki-67/MIB-1 expression in 30% of the nuclei.</p>
</caption>
<graphic alternate-form-of="fig5-0883073812441061" xlink:href="10.1177_0883073812441061-fig5.tif"/>
</fig>
</sec>
<sec id="section2-0883073812441061">
<title>Discussion</title>
<p>Spinal cord tumors in children are rare, and only 35%-40% of these tumors are intradural. The majority are astrocytomas, followed by gangliogliomas and ependymomas.<sup><xref ref-type="bibr" rid="bibr7-0883073812441061">7</xref>,<xref ref-type="bibr" rid="bibr8-0883073812441061">8</xref></sup> Primitive neuroectodermal tumor constitute approximately 1% of intraspinal tumors.<sup><xref ref-type="bibr" rid="bibr9-0883073812441061">9</xref>,<xref ref-type="bibr" rid="bibr10-0883073812441061">10</xref></sup> Furthermore, only one infantile case has been reported to date.<sup><xref ref-type="bibr" rid="bibr1-0883073812441061">1</xref></sup> In that case, seeding along the intracranial subarachnoid space had also been observed; however, the patient had no signs of hydrocephalus.<sup><xref ref-type="bibr" rid="bibr2-0883073812441061">2</xref></sup>
</p>
<p>Hydrocephalus in the presence of an intramedullary tumor is a rare phenomenon. Rifkinson-Mann et al in a series of 171 patients with intramedullary spinal cord tumors reported that 25 patients (15%), mostly children, developed symptomatic hydrocephalus.<sup><xref ref-type="bibr" rid="bibr5-0883073812441061">5</xref></sup> Various mechanisms have been proposed; nevertheless, an adequate proven explanation is still lacking.<sup><xref ref-type="bibr" rid="bibr4-0883073812441061">4</xref></sup> In the present case, we believe that intracranial tumoral dissemination caused the development of hydrocephalus. Primitive neuroectodermal tumors are malignant embryonal tumors that are categorized as central nervous system primitive neuroectodermal tumors and peripheral primitive neuroectodermal tumors, which are members of the EWING sarcomas/peripheral primitive neuroectodermal tumor family. The latter is characterized by the chromosomal translocation t(11;22)(q24;q12) in almost 90% of cases.<sup><xref ref-type="bibr" rid="bibr11-0883073812441061">11</xref></sup> Furthermore, peripheral primitive neuroectodermal tumors are known to metastasize outside the central nervous system, whereas central nervous system primitive neuroectodermal tumor only rarely do. However, they are associated with leptomeningeal spread at diagnosis.<sup><xref ref-type="bibr" rid="bibr12-0883073812441061">12</xref></sup> Central nervous system primitive neuroectodermal tumors are believed to arise from neoplastic transformation of primitive neuroepithelial cells in subependymal zones and are composed of small cells, with high nuclear-to-cytoplasmic ratio, high mitotic rate that exhibits divergent differentiation of variable degree along neuronal, glial, or rarely mesenchymal lines.<sup><xref ref-type="bibr" rid="bibr12-0883073812441061">12</xref></sup> Their immunohistochemical profile varies according to their lines of differentiation. Our case was mainly characterized by a neuronal differentiation, identified by morphology and confirmed by the expression of neuronal markers. Although central nervous system primitive neuroectodermal tumors are usually located supratentorially, mainly in the cerebral hemispheres, they have been reported to arise in several sites of the neuraxis. Spinal primitive neuroectodermal tumors are exceedingly rare and can be found intramedullary, intradural-extramedullary, and extradurally. Furthermore, they seem to have a predilection for the thoracic region.<sup><xref ref-type="bibr" rid="bibr13-0883073812441061">13</xref></sup> Because the clinical presentation and the radiologic findings are of limited value in establishing the diagnosis, a histologic verification is always mandatory. Complete surgical resection is usually impossible because these tumors do not have a clear plane of cleavage between tumor and neural structures; consequently, complete excision can result in additional neurologic deficits or even paralysis. Surgical resection is usually followed by radiotherapy and chemotherapy.<sup><xref ref-type="bibr" rid="bibr1-0883073812441061">1</xref>,<xref ref-type="bibr" rid="bibr14-0883073812441061">14</xref></sup> Nevertheless, these tumors exhibit aggressive clinical course and in the majority of cases progression or recurrence has been reported despite multimodal aggressive treatment protocols.<sup><xref ref-type="bibr" rid="bibr10-0883073812441061">10</xref>,<xref ref-type="bibr" rid="bibr13-0883073812441061">13</xref>,<xref ref-type="bibr" rid="bibr15-0883073812441061">15</xref><xref ref-type="bibr" rid="bibr16-0883073812441061"/>–<xref ref-type="bibr" rid="bibr17-0883073812441061">17</xref></sup> In conclusion spinal intramedullary primitive neuroectodermal tumors are extremely rare and carry a dismal prognosis. Clearly further multiinstitutional studies are needed, especially in such rare tumors, for treatment guidelines to be established.</p>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="other" id="fn1a-0883073812441061"><label>Author Contributions</label>
<p>GA, KS, and NP designed the study. NP and GA performed the operation. KS and GS performed all the immunohistochemical stainings and analyzed and interpreted the data. MM provided all the details regarding the treatment and follow-up of these patients and helped in data interpretation. GA, GS, and KS prepared the manuscript. GA, KS, NP, and MM interpreted the overall results. GA, KS, MM, and NP critically revised the manuscript. The manuscript was finally approved by GA, KS, MM, GS, and NP.</p>
</fn>
<fn fn-type="conflict" id="fn1-0883073812441061"><label>Declaration of Conflicting Interests</label>
<p>The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article. </p>
</fn>
<fn fn-type="financial-disclosure" id="fn2-0883073812441061"><label>Funding</label>
<p>The authors received no financial support for the research, authorship, and/or publication of this article. </p>
</fn>
<fn fn-type="financial-disclosure" id="fn2a-0883073812441061"><label>Ethical Approval</label>
<p>Institutional Review Board approval and parental consent were obtained for this study.</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="bibr1-0883073812441061">
<label>1</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ellis</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Rothrock</surname>
<given-names>RJ</given-names>
</name>
<name>
<surname>Moise</surname>
<given-names>G</given-names>
</name>
<etal/>
</person-group> <article-title>Primitive neuroectodermal tumors of the spine: a comprehensive review with illustrative clinical cases</article-title>. <source>Neurosurg Focus</source>. <year>2011</year>;<fpage>30</fpage>: <volume>E1</volume>.</citation>
</ref>
<ref id="bibr2-0883073812441061">
<label>2</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kwon</surname>
<given-names>OK</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>KC</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>CJ</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>IO</given-names>
</name>
<name>
<surname>Chi</surname>
<given-names>JG</given-names>
</name>
<name>
<surname>Cho</surname>
<given-names>BK</given-names>
</name>
</person-group>. <article-title>Primary intramedullary spinal cord primitive neuroectodermal tumor with intracranial seeding in an infant</article-title>. <source>Childs Nerv Syst</source>. <year>1996</year>;<volume>12</volume>:<fpage>633</fpage>–<lpage>636</lpage>.</citation>
</ref>
<ref id="bibr3-0883073812441061">
<label>3</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>McGirt</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Chaichana</surname>
<given-names>KL</given-names>
</name>
<name>
<surname>Atiba</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Attenello</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Yao</surname>
<given-names>KC</given-names>
</name>
<name>
<surname>Jallo</surname>
<given-names>GI</given-names>
</name>
</person-group>. <article-title>Resection of intramedullary spinal cord tumors in children: assessment of long-term motor and sensory deficits</article-title>. <source>J Neurosurg Pediatr</source>. <year>2008</year>;<volume>1</volume>:<fpage>63</fpage>–<lpage>67</lpage>.</citation>
</ref>
<ref id="bibr4-0883073812441061">
<label>4</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Miller</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Towfighi</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Page</surname>
<given-names>RB</given-names>
</name>
</person-group>. <article-title>Spinal cord ganglioglioma presenting as hydrocephalus</article-title>. <source>J Neurooncol</source>. <year>1990</year>;<volume>9</volume>:<fpage>147</fpage>–<lpage>152</lpage>.</citation>
</ref>
<ref id="bibr5-0883073812441061">
<label>5</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rifkinson-Mann</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Wisoff</surname>
<given-names>JH</given-names>
</name>
<name>
<surname>Epstein</surname>
<given-names>F</given-names>
</name>
</person-group>. <article-title>The association of hydrocephalus with intramedullary spinal cord tumors: a series of 25 patients</article-title>. <source>Neurosurgery</source>. <year>1990</year>;<volume>27</volume>:<fpage>749</fpage>–<lpage>754</lpage>.</citation>
</ref>
<ref id="bibr6-0883073812441061">
<label>6</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chi</surname>
<given-names>SN</given-names>
</name>
<name>
<surname>Gardner</surname>
<given-names>SL</given-names>
</name>
<name>
<surname>Levy</surname>
<given-names>AS</given-names>
</name>
<etal/>
</person-group> <article-title>Feasibility and response to induction chemotherapy intensified with high-dose methotrexate for young children with newly diagnosed high-risk disseminated medulloblastoma</article-title>. <source>J Clin Oncol</source>. <year>2004</year>;<volume>22</volume>:<fpage>4881</fpage>–<lpage>4887</lpage>.</citation>
</ref>
<ref id="bibr7-0883073812441061">
<label>7</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Constantini</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Miller</surname>
<given-names>DC</given-names>
</name>
<name>
<surname>Allen</surname>
<given-names>JC</given-names>
</name>
<name>
<surname>Rorke</surname>
<given-names>LB</given-names>
</name>
<name>
<surname>Freed</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Epstein</surname>
<given-names>FJ</given-names>
</name>
</person-group>. <article-title>Radical excision of intramedullary spinal cord tumors: surgical morbidity and long-term follow-up evaluation in 164 children and young adults</article-title>. <source>J Neurosurg</source>. <year>2000</year>;<volume>93</volume>(<issue>2 suppl</issue>):<fpage>183</fpage>–<lpage>193</lpage>.</citation>
</ref>
<ref id="bibr8-0883073812441061">
<label>8</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Miller</surname>
<given-names>DC</given-names>
</name>
</person-group>. <article-title>Surgical pathology of intramedullary spinal cord neoplasms</article-title>. <source>J Neurooncol</source>. <year>2000</year>;<volume>47</volume>:<fpage>189</fpage>–<lpage>194</lpage>.</citation>
</ref>
<ref id="bibr9-0883073812441061">
<label>9</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Engelhard</surname>
<given-names>HH</given-names>
</name>
<name>
<surname>Villano</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Porter</surname>
<given-names>KR</given-names>
</name>
<etal/>
</person-group> <article-title>Clinical presentation, histology, and treatment in 430 patients with primary tumors of the spinal cord, spinal meninges, or cauda equina</article-title>. <source>J Neurosurg Spine</source>. <year>2010</year>;<volume>13</volume>:<fpage>67</fpage>–<lpage>77</lpage>.</citation>
</ref>
<ref id="bibr10-0883073812441061">
<label>10</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Freyer</surname>
<given-names>DR</given-names>
</name>
<name>
<surname>Hutchinson</surname>
<given-names>RJ</given-names>
</name>
<name>
<surname>McKeever</surname>
<given-names>PE</given-names>
</name>
</person-group>. <article-title>Primary primitive neuroectodermal tumor of the spinal cord associated with neural tube defect</article-title>. <source>Pediatr Neurosci</source>. <year>1989</year>;<volume>15</volume>:<fpage>181</fpage>–<lpage>187</lpage>.</citation>
</ref>
<ref id="bibr11-0883073812441061">
<label>11</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Delattre</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Zucman</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Melot</surname>
<given-names>T</given-names>
</name>
<etal/>
</person-group> <article-title>The Ewing family of tumors—a subgroup of small-round-cell tumors defined by specific chimeric transcripts</article-title>. <source>N Engl J Med</source>. <year>1994</year>;<volume>331</volume>:<fpage>294</fpage>–<lpage>299</lpage>.</citation>
</ref>
<ref id="bibr12-0883073812441061">
<label>12</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rorke</surname>
<given-names>LB</given-names>
</name>
</person-group>. <article-title>The cerebellar medulloblastoma and its relationship to primitive neuroectodermal tumors</article-title>. <source>J Neuropathol Exp Neurol</source>. <year>1983</year>;<volume>42</volume>:<fpage>1</fpage>–<lpage>15</lpage>.</citation>
</ref>
<ref id="bibr13-0883073812441061">
<label>13</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Otero-Rodríguez</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Hinojosa</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Esparza</surname>
<given-names>J</given-names>
</name>
<etal/>
</person-group> <article-title>Purely intramedullary spinal cord primitive neuroectodermal tumor: case report and review of the literature</article-title>. <source>Neurocirugia (Astur)</source>. <year>2009</year>;<volume>20</volume>:<fpage>381</fpage>–<lpage>386</lpage>.</citation>
</ref>
<ref id="bibr14-0883073812441061">
<label>14</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gollard</surname>
<given-names>RP</given-names>
</name>
<name>
<surname>Rosen</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Anson</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Mason</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Khoury</surname>
<given-names>J</given-names>
</name>
</person-group>. <article-title>Intramedullary PNET of the spine: long-term survival after combined modality therapy and subsequent relapse</article-title>. <source>J Pediatr Hematol Oncol</source>. <year>2011</year>;<volume>33</volume>:<fpage>107</fpage>–<lpage>112</lpage>.</citation>
</ref>
<ref id="bibr15-0883073812441061">
<label>15</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Albrecht</surname>
<given-names>CF</given-names>
</name>
<name>
<surname>Weiss</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Schultz-Schaeffer</surname>
<given-names>WJ</given-names>
</name>
</person-group>. <article-title>Primary intraspinal primitive neuroectodermal tumor: report of two cases and review of literature</article-title>. <source>J Neurooncol</source>. <year>2003</year>;<volume>61</volume>:<fpage>113</fpage>–<lpage>120</lpage>.</citation>
</ref>
<ref id="bibr16-0883073812441061">
<label>16</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Deme</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Ang</surname>
<given-names>LC</given-names>
</name>
<name>
<surname>Skaf</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Rowed</surname>
<given-names>DW</given-names>
</name>
</person-group>. <article-title>Primary intramedullary primitive neuroectodermal tumor of the spinal cord: case report and review of the literature</article-title>. <source>Neurosurgery</source>. <year>1997</year>;<volume>41</volume>:<fpage>1417</fpage>–<lpage>1420</lpage>
</citation>
</ref>
<ref id="bibr17-0883073812441061">
<label>17</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kampman</surname>
<given-names>WA</given-names>
</name>
<name>
<surname>Kros</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>De Jong</surname>
<given-names>TH</given-names>
</name>
<name>
<surname>Lequin</surname>
<given-names>MH</given-names>
</name>
</person-group>. <article-title>Primitive neuroectodermal tumours (PNETs) located in the spinal canal; the relevance of classification as central or peripheral PNET: case report of a primary spinal PNET occurrence with a critical literature review</article-title>. <source>J Neurooncol</source>. <year>2006</year>;<volume>77</volume>:<fpage>65</fpage>–<lpage>72</lpage>.</citation>
</ref>
</ref-list>
</back>
</article>